Quick Answer
Artiva Biotherapeutics, Inc. reported Total Assets of $130.94 million for the year ending 2025.
- Artiva Biotherapeutics, Inc. showed a decrease of -37.5% in Total Assets from 2024 to 2025.
- This data is from Artiva Biotherapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 10, 2026.
- XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2024: $75.91 million | Q3 2024: $225.60 million | Q1 2025: $191.26 million | Q2 2025: $169.39 million | Q3 2025: $148.86 million.
- Over the full 3 years of available data (2023 to 2025), Artiva Biotherapeutics, Inc.'s Total Assets has grown by 24.6%.
- Historical annual values: Fiscal year 2025: $130.94 million | Fiscal year 2024: $209.58 million | Fiscal year 2023: $105.11 million.
- Data sourced from SEC EDGAR public filings as of August 4, 2026.
Last verified: